Silicon Valley's bustling biotech hub has attracted a new investor willing to pay a premium price with the $81 million sale of a Redwood City office complex.
Silicon Valley's bustling biotech hub has attracted a new investor willing to pay a premium price with the $81 million sale of a Redwood City office complex.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
130 Shoreline Dr, Redwood City, CA